253 related articles for article (PubMed ID: 14688091)
1. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
[TBL] [Abstract][Full Text] [Related]
2. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
[TBL] [Abstract][Full Text] [Related]
3. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.
Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H
Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308
[TBL] [Abstract][Full Text] [Related]
4. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil.
Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML
Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188
[TBL] [Abstract][Full Text] [Related]
6. The Overlooked Glycan Components of the Cryptococcus Capsule.
Fonseca FL; Reis FCG; Sena BAG; Jozefowicz LJ; Kmetzsch L; Rodrigues ML
Curr Top Microbiol Immunol; 2019; 422():31-43. PubMed ID: 30203395
[TBL] [Abstract][Full Text] [Related]
7. Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells.
Teixeira PA; Penha LL; Mendonça-Previato L; Previato JO
Front Cell Infect Microbiol; 2014; 4():106. PubMed ID: 25191644
[TBL] [Abstract][Full Text] [Related]
8. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.
Villena SN; Pinheiro RO; Pinheiro CS; Nunes MP; Takiya CM; DosReis GA; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
Cell Microbiol; 2008 Jun; 10(6):1274-85. PubMed ID: 18284419
[TBL] [Abstract][Full Text] [Related]
9. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
Retini C; Vecchiarelli A; Monari C; Bistoni F; Kozel TR
Infect Immun; 1998 Feb; 66(2):664-9. PubMed ID: 9453624
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection.
LaRocque-de-Freitas IF; Rocha JDB; Nunes MP; Oliveira PAV; Nascimento DO; Freire-de-Lima L; Takiya CM; Morrot A; Decote-Ricardo D; Previato JO; DosReis GA; Mendonça-Previato L; Freire-de-Lima CG
Sci Rep; 2018 Nov; 8(1):16378. PubMed ID: 30401972
[TBL] [Abstract][Full Text] [Related]
12. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.
Jesus MD; Nicola AM; Chow SK; Lee IR; Nong S; Specht CA; Levitz SM; Casadevall A
Virulence; 2010; 1(6):500-8. PubMed ID: 21178496
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival.
Geunes-Boyer S; Oliver TN; Janbon G; Lodge JK; Heitman J; Perfect JR; Wright JR
Infect Immun; 2009 Jul; 77(7):2783-94. PubMed ID: 19451250
[TBL] [Abstract][Full Text] [Related]
14. Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.
Lee HH; Carmichael DJ; Ríbeiro V; Parisi DN; Munzen ME; Charles-Niño CL; Hamed MF; Kaur E; Mishra A; Patel J; Rooklin RB; Sher A; Carrillo-Sepulveda MA; Eugenin EA; Dores MR; Martinez LR
PLoS Pathog; 2023 Apr; 19(4):e1010941. PubMed ID: 37115795
[TBL] [Abstract][Full Text] [Related]
15. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.
Schelenz S; Malhotra R; Sim RB; Holmskov U; Bancroft GJ
Infect Immun; 1995 Sep; 63(9):3360-6. PubMed ID: 7642263
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D facilitates Cryptococcus neoformans infection.
Geunes-Boyer S; Beers MF; Perfect JR; Heitman J; Wright JR
Infect Immun; 2012 Jul; 80(7):2444-53. PubMed ID: 22547543
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.
Patel D; Desai GM; Frases S; Cordero RJ; DeLeon-Rodriguez CM; Eugenin EA; Nosanchuk JD; Martinez LR
mBio; 2013 Jul; 4(4):. PubMed ID: 23900172
[TBL] [Abstract][Full Text] [Related]
18. The capsule of the fungal pathogen Cryptococcus neoformans.
Zaragoza O; Rodrigues ML; De Jesus M; Frases S; Dadachova E; Casadevall A
Adv Appl Microbiol; 2009; 68():133-216. PubMed ID: 19426855
[TBL] [Abstract][Full Text] [Related]
19. Dectin-3 Recognizes Glucuronoxylomannan of
Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
Front Immunol; 2018; 9():1781. PubMed ID: 30131805
[No Abstract] [Full Text] [Related]
20. Killing of cryptococcus neoformans by Staphylococcus aureus: the role of cryptococcal capsular polysaccharide in the fungal-bacteria interaction.
Saito F; Ikeda R
Med Mycol; 2005 Nov; 43(7):603-12. PubMed ID: 16396245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
